Cleavage fragments of the third complement component (C3) enhance stromal derived factor-1 (SDF-1)-mediated platelet production during reactive postbleeding thrombocytosisWYSOCZYNSKI, M; KUCIA, M; RATAJCZAK, J et al.Leukemia. 2007, Vol 21, Num 5, pp 973-982, issn 0887-6924, 10 p.Article

Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cellsRATAJCZAK, M. Z; RECA, R; WYSOCZYNSKI, M et al.Leukemia. 2004, Vol 18, Num 9, pp 1482-1490, issn 0887-6924, 9 p.Article

CXCR4 in Clinical HematologyCALANDRA, Gary; BRIDGER, Gary; FRICKER, Simon et al.Current Topics in Microbiology and Immunology. 2010, Vol 341, pp 173-191, issn 0070-217X, 19 p.Article

Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemiaO'CALLAGHAN, Katie; LEE, Lydia; NGUYEN, Nga et al.Blood. 2012, Vol 119, Num 7, pp 1717-1725, issn 0006-4971, 9 p.Article

Genetics on a WHIMOMAR AL USTWANI, Omar; KURZROCK, Razelle; WETZLER, Meir et al.British journal of haematology. 2014, Vol 164, Num 1, pp 15-23, issn 0007-1048, 9 p.Article

Characterization of Nef-CXCR4 interactions important for apoptosis inductionHUANG, Ming-Bo; LING LING JIN; JAMES, Cleve O et al.Journal of virology. 2004, Vol 78, Num 20, pp 11084-11096, issn 0022-538X, 13 p.Article

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progressionXUEQING SUN; GUANGCUN CHENG; MINGANG HAO et al.Cancer metastasis reviews. 2010, Vol 29, Num 4, pp 709-722, issn 0167-7659, 14 p.Article

Photolabeling identifies transmembrane domain 4 of CXCR4 as a T140 binding siteBOULAIS, Philip E; DULUDE, Dominic; CABANA, Jérôme et al.Biochemical pharmacology. 2009, Vol 78, Num 11, pp 1382-1390, issn 0006-2952, 9 p.Article

Nef proteins from diverse groups of primate lentiviruses downmodulate CXCR4 to inhibit migration to the chemokine stromal derived factor 1HRECKA, Kasia; SWIGUT, Tomek; SCHINDLER, Michael et al.Journal of virology. 2005, Vol 79, Num 16, pp 10650-10659, issn 0022-538X, 10 p.Article

The AMD3100 story : The path to the discovery of a stem cell mobilizer (Mozobil)DE CLERCQ, Erik.Biochemical pharmacology. 2009, Vol 77, Num 11, pp 1655-1664, issn 0006-2952, 10 p.Article

Marginal expression of CXCR4 on c-kit⁺Sca-1⁺Lineage^- hematopoietic stem/progenitor cellsSASAKI, Yutaka; MATSUOKA, Yoshikazu; HASE, Makoto et al.International journal of hematology. 2009, Vol 90, Num 5, pp 553-560, issn 0925-5710, 8 p.Article

Surface expression of neutrophil CXCR4 is down-modulated by bacterial endotoxinHYUN KYUNG KIM; KIM, Ji-Eun; CHUNG, Junho et al.International journal of hematology. 2007, Vol 85, Num 5, pp 390-396, issn 0925-5710, 7 p.Article

HIV tropism : diagnostic tools and implications for disease progression and treatment with entry inhibitorsPOVEDA, Eva; BRIZ, Veronica; QUINONES-MATEU, Miguel et al.AIDS (London). 2006, Vol 20, Num 10, pp 1359-1367, issn 0269-9370, 9 p.Article

Sequential administration of the high affinity CXCR4 antagonist BKT140 promotes megakaryopoiesis and platelet productionABRAHAM, Michal; WEISS, Ido D; WALD, Hanna et al.British journal of haematology. 2013, Vol 163, Num 2, pp 248-259, issn 0007-1048, 12 p.Article

Low CXCR4 membrane expression on CD34 + cells characterizes cells mobilized to bloodDLUBEK, D; DRABCZAK-SKRZYPEK, D; LANGE, A et al.Bone marrow transplantation (Basingstoke). 2006, Vol 37, Num 1, pp 19-23, issn 0268-3369, 5 p.Article

The CXCL12―CXCR4 Chemokine Pathway: A Novel Axis Regulates LymphangiogenesisWEI ZHUO; LIN JIA; NAN SONG et al.Clinical cancer research (Print). 2012, Vol 18, Num 19, pp 5387-5398, issn 1078-0432, 12 p.Article

Expression of Chemokine CXCL12 and Its Receptor CXCR4 in Folliculostellate (FS) Cells of the Rat Anterior Pituitary Gland: The CXCL12/CXCR4 Axis Induces Interconnection of FS CellsHORIGUCHI, Kotaro; ILMIAWATI, Cimi; FUJIWARA, Ken et al.Endocrinology (Philadelphia). 2012, Vol 153, Num 4, pp 1717-1724, issn 0013-7227, 8 p.Article

Clinical significance of chemokine receptor (CCR1, CCR2 and CXCR4) expression in human myeloma cells : the association with disease activity and survivalVAN DE BROEK, Isabelle; LELEU, Xavier; SCHOTS, Rik et al.Haematologica (Roma). 2006, Vol 91, Num 2, pp 200-206, issn 0390-6078, 7 p.Article

Plerixafor 'just in time' for stem cell mobilization in a normal donorSCHRIBER, J; FAUBLE, V; SPROAT, L. O et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 7, pp 1026-1027, issn 0268-3369, 2 p.Article

The role of stromal-derived factor-1: CXCR7 axis in development and cancerMAKSYM, Radoslaw B; TARNOWSKI, Maciej; GRYMULA, Katarzyna et al.European journal of pharmacology. 2009, Vol 625, Num 1-3, pp 31-40, issn 0014-2999, 10 p.Article

Induction of simian AIDS in infant rhesus macaques infected with CCR5- or CXCR4-utilizing simian-human immunodeficiency viruses is associated with distinct lesions of the thymusREYES, R. A; CANFIELD, Don R; ESSER, Ursula et al.Journal of virology. 2004, Vol 78, Num 4, pp 2121-2130, issn 0022-538X, 10 p.Article

Prospective study of mobilization kinetics up to 18 hours after late-afternoon dosing of plerixaforSHI, Patricia A; MILLER, Lorraine K; ISOLA, Luis M et al.Transfusion (Philadelphia, PA). 2014, Vol 54, Num 5, pp 1263-1268, issn 0041-1132, 6 p.Article

Mobilization studies in complement-deficient mice reveal that optimal AMD3100 mobilization of hematopoietic stem cells depends on complement cascade activation by AMD3100-stimulated granulocytesLEE, H. M; WYSOCZYNSKI, M; LIU, R et al.Leukemia. 2010, Vol 24, Num 3, pp 573-582, issn 0887-6924, 10 p.Article

The evolving role of plerixafor in hematopoietic progenitor cell mobilizationTANHEHCO, Yvette C; VOGL, Dan T; STADTMAUER, Edward A et al.Transfusion (Philadelphia, PA). 2013, Vol 53, Num 10, pp 2314-2326, issn 0041-1132, 13 p., 1Article

Sequential desensitization of CXCR4 and S1P5 controls natural killer cell traffickingMAYOL, Katia; BIAJOUX, Vincent; MARVEL, Jacqueline et al.Blood. 2011, Vol 118, Num 18, pp 4863-4871, issn 0006-4971, 9 p.Article